Search results
Octane Medical acquires B. Braun’s global orthobiologics business
Digital Journal· 3 days agoOctane Medical Group, through its new venture Octane Biotherapeutics (BioTx), has acquired 100% shares of the global orthobiologics business from its long-term partner B. Braun. The acquisition ...
Longeveron enters contract manufacturing with Secretome deal By Investing.com
Investing.com· 7 days agoLongeveron Inc. (NASDAQ: LGVN), a biotech company specializing in regenerative medicine, has...
SANUWAVE Will Host a Conference Call on June 4, 2024 at 8:30 AM (ET) to Provide a Corporate Update
NewMediaWire via Yahoo Finance· 7 days agoEDEN PRAIRIE, MN - (NewMediaWire) - June 03, 2024 - SANUWAVE Health, Inc. (the "Company" or...
FibroBiologics Shares Up 38% on Withdrawn Equity Offering
Market Watch· 4 days agoFibroBiologics shares rose Thursday after the cell therapy and regenerative medicine company said it will no longer pursue a planned equity offering. The ...
Celularity reports advances in cancer T-cell therapy By Investing.com
Investing.com· 7 days agoCelularity Inc. (NASDAQ: CELU), a biotechnology firm specializing in regenerative medicine,...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 7 days agoLongeveron (NASDAQ: LGVN) is a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic ...
Humacyte CEO Niklason buys $15k in company stock By Investing.com
Investing.com· 7 days agoNiklason purchased shares worth approximately $15,000. The transaction, dated June 3, 2024, involved...
CollPlant prints commercial-size regenerative breast implants By Investing.com
Investing.com· 3 days agoCollPlant Biotechnologies (NASDAQ:CLGN), an innovator in regenerative and aesthetic medicine, has...
New technique could protect stem cells
UB Reporter· 7 hours agoInjecting shear-thinning hydrogels (STH) into the brain protects the stem cells and results in more successful therapy. When the myelin sheath that surrounds nerve fibers in the brain and spinal ...
Mesoblast (NASDAQ:MESO) Receives Overweight Rating from Cantor Fitzgerald
ETF DAILY NEWS· 5 days agoCantor Fitzgerald reaffirmed their overweight rating on shares of Mesoblast (NASDAQ:MESO – Free Report) in a report released on Tuesday, Benzinga reports. Separately, StockNews.com downgraded ...
